Nova Eye Medical Limited (EYE) Q4 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nova Eye Medical Ltd.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.633 -- 00:00:05.415 Okay, good morning everybody and thanks again for joining us. 00:00:05.415 -- 00:00:08.757 My name is Mark Flynn, Investor Relations at Novi Medical. 00:00:08.757 -- 00:00:13.040 Today we're covering the June 26th quarterly report which we lodged last week with the 00:00:13.040 -- 00:00:17.743 ASX and also we'll provide some outlook on FY27. 00:00:17.743 -- 00:00:21.746 Presenting as always today is Tom Sperling, our Managing Director. 00:00:21.746 -- 00:00:26.075 Again, Q&A available if you look inside Zoom. 00:00:26.075 -- 00:00:29.697 Q&A function. We'll look to get to as many questions as possible. 00:00:29.697 -- 00:00:33.398 Also, we can follow up post the webinar, but I will ask a number of questions. 00:00:33.398 -- 00:00:37.180 So please place them in the Q&A function within Zoom. 00:00:37.180 -- 00:00:41.902 As we can see from the recent results, Tom's led the company through a wonderful four 00:00:41.902 -- 00:00:44.143 consecutive years of sales growth, above 25%. 00:00:44.143 -- 00:00:49.545 And our FY26 closed at just below US$24 million, 00:00:49.545 -- 00:00:54.628 up 26%. And the second half delivered the company's first positive EBITDA as guided 00:00:54.628 -- 00:00:59.623 by Tom and the team. So Tom will take you through these results, what drove it, and also 00:00:59.623 -- 00:01:04.506 it provides an FY27 guidance. So over to you, Tom. 00:01:04.506 -- 00:01:10.429 Thanks, Mark. I'm very pleased, again, to be speaking and talking to our company. 00:01:11.071 -- 00:01:15.734 It's another record attendance, and having a lot of people interested in our company, 00:01:15.734 -- 00:01:19.357 another record attendance webinar, having a lot of people interested in our company is 00:01:19.357 -- 00:01:23.220 very, I'll...